Cancer

7 results.

July 28, 2023 Alternative cellular ‘fuels’ boost immunity

GRAND RAPIDS, Mich. (July 28, 2023) — A metabolic by-product that is more prevalent during fasting may supercharge immune cells as they fight infection and…

May 11, 2023 Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

GRAND RAPIDS, Mich. (May 11, 2023) — Van Andel Institute scientists have pinpointed how a specific gene mutation triggers an inflammatory cascade that may…

October 20, 2021 American Cancer Society grant to support Van Andel Institute research into anti-cancer medications

GRAND RAPIDS, Mich. (Oct. 20, 2021) — Van Andel Institute’s Scott Rothbart, Ph.D., has earned a four-year, $792,000 Research…

September 22, 2021 Coriell Institute for Medical Research, Van Andel Institute awarded estimated $12.4 million SPORE grant from National Cancer Institute

Estimated at $12.4 million, this five-year grant supports a nationwide team of researchers investigating epigenetic therapies for cancer The Coriell Institute for Medical Research and…

August 18, 2021 Van Andel Institute earns prestigious grant to train postdoctoral fellows in cancer epigenetics

GRAND RAPIDS, Mich. (Aug. 18, 2021) — The National Cancer Institute has awarded Van Andel Institute a five-year, $1.7 million grant to establish a…

April 4, 2019 Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer

GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a protein called…

November 28, 2018 High-throughput platform enables scientists to map activity of an emerging class of cancer drug targets

GRAND RAPIDS, Mich. (Nov. 28, 2018) — A powerful new biochemical platform is fueling the study of a family of enzymes that are promising targets for…